Thoracic Vascular Stent Grafts Market Size

Thoracic Vascular Stent Grafts Market size was valued at USD 219.31 million in 2024 and is likely to cross USD 473.54 million by 2037, registering more than 6.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of thoracic vascular stent grafts is estimated at USD 241.24 million.

The growth of the market can be attributed to the increasing prevalence of cardiovascular diseases throughout the world. According to the data provided by the World Health Organization (WHO), every year, approximately 17.9 million individuals die from CVDs throughout the world, accounting for 32% of all deaths. Further, dramatically changing eating habits, and evolving lifestyles are some further factors that are anticipated to boost the growth of the global thoracic vascular stent grafts market over the projected time frame.

In addition to these, factors that are believed to fuel the market growth of thoracic vascular stent grafts include the rising death toll of aneurysms throughout the world, coupled with the increasing proportion of the geriatric population. For instance, aortic aneurysm-related mortality is estimated to cause around 160,000–232,000 deaths annually across the globe with a survival rate of less than 20%. In addition to this, significant approval of thoracic vascular stent grafts by the FDA, along with surging awareness regarding these grafts, are further major factors that are estimated to expand the demand for thoracic vascular stent grafts over the forecast period.